Teikoku Pharma USA, Inc.

DEXMDERM

Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of withdrawal syndromes; topical preparations for use in the management of pain; and topical preparations for use in providing sedation;

DEXMDERM

Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or substance withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation, namely, sedatives, anaesthetics, general anesthetics, anesthetic for surgical use, anesthetics for non-surgical use; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety, Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of substance withdrawal syndromes; Pharmaceutical preparations, namely, topical preparations for use in the management of pain; Pharmaceutical preparations, namely, topical preparations for use in providing sedation, namely, sedatives, anaesthetics, general anesthetics, anesthetic for surgical use, anesthetics for non-surgical use;

DEXY PATCH

Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of withdrawal syndromes; topical preparations for use in the management of pain; and topical preparations for use in providing sedation;PATCH;

DEXY PATCH

Transdermal patches for use in the treatment of substance withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation, namely, sedatives, anesthetics, general anesthetics, anesthetics for non-surgical use; Pharmaceutical preparations, namely, topical preparations for use in the treatment of substance withdrawal syndromes; Pharmaceutical preparations, namely, topical preparations for use in the management of pain; and Pharmaceutical preparations, namely, topical preparations for use in providing sedation, namely, sedatives, anesthetics, general anesthetics, anesthetics for non-surgical use;PATCH;

DEXYDERM

Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of withdrawal syndromes; topical preparations for use in the management of pain; and topical preparations for use in providing sedation;

DEXYDERM

Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or substance withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation, namely, sedatives, anaesthetics, general anesthetics, anesthetic for surgical use, anesthetics for non-surgical use; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of substance withdrawal syndromes; Pharmaceutical preparations, namely, topical preparations for use in the management of pain; Pharmaceutical preparations, namely, topical preparations for use in providing sedation, namely, sedatives, anaesthetics, general anesthetics, anesthetic for surgical use, anesthetics for non-surgical use;DEXY DERM;

E-PATCH

Transdermal drug delivery patches for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, vitamin imbalance, gastrointestinal conditions, inflammation, skin conditions, infectious diseases, asthma, hormonal imbalance and pain;EYE-PATCH;Transdermal drug delivery patches sold without medication;

EKSTERMED

Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions;Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; non-medicated soaps for personal use; perfumery; essential oils; hair lotions;

EKSTERMED

The mark consists of the word, EksterMed with Ekster in dark blue and Med in lighter blue. Above the wording is a design consisting of seventy-five small circles lined both horizontally and vertically, forming a shape of a plus symbol. The size of the circles is large in the inner part and dark blue and the circles become light blue and smaller toward the outer part.;Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions;Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; non-medicated soaps for personal use; perfumery; essential oils; hair lotions;The color(s) light blue and dark blue is/are claimed as a feature of the mark.;